Viewing nowGlipide Tablet (Glimepiride)
Glimepiride 2mg
Tablet · Prescription medication
Hybeast Pharmaceutical Co., Ltd.

MFDS item code 201403732 · Approved 2014.08.12 · Insurance code 628800080
Improvement of blood glucose control in type 2 diabetes mellitus
This medication is used as an adjunct to diet and exercise to help control blood sugar in patients with Type 2 diabetes. It can be used alone and may also be administered in combination with oral hypoglycemics or insulin. It is particularly used in combination with Metformin when blood sugar control is insufficient with monotherapy using a sulfonylurea or Metformin. This helps manage blood sugar levels more effectively, aiding in the improvement of diabetes symptoms.
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. Administer this medicine orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, there is little additional effect at doses above 4 mg, although some patients have achieved better metabolic control with doses increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control may improve during treatment, the amount of this medicine required may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral blood-glucose-lowering medicine to this medicine There is no precise dose equivalence between this medicine and other oral blood-glucose-lowering medicines. When switching from another oral blood-glucose-lowering medicine to this medicine, it is recommended to follow the instructions under Initial dose. That is, initiate treatment with 1 mg daily and adjust the dose at 1 ~ 2-week intervals. The potency and duration of action of the previously administered medicine should be taken into consideration. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly; regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia is promptly controlled by immediately taking sugar. Hypoglycemia may recur even after it has been successfully managed initially during treatment with a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate treatment and follow-up by a physician and may sometimes require hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy of this medicine with insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and initiate insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin dose adjustment is required periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Clinical information has been published on combination therapy of metformin with other sulfonylureas, such as glyburide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered concomitantly with metformin, and the risk may increase. Appropriate caution should be exercised.
This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or those in a coma. Additionally, it should not be administered to patients allergic to this medication, sulfonylureas, or sulfonamide medications, or those with severe liver or kidney dysfunction. Pregnant or nursing women should not take this medication, and it is recommended to switch to insulin therapy in cases of severe infections, pre- or post-surgery, or severe trauma. Caution should be taken when gastrointestinal side effects such as diarrhea or vomiting occur, as they may lead to hypoglycemia due to problems with food absorption. This medication contains lactose and should not be given to patients with lactose intolerance or certain genetic metabolic disorders. During the first week of treatment, the risk of hypoglycemia is high, so blood sugar should be checked frequently and closely monitored. Elderly patients, those with poor nutritional status or irregular eating habits, and those with decreased kidney or liver function are at higher risk for hypoglycemia. When taking this medication with other drugs, interactions may affect blood sugar control, so consultation with a doctor is necessary. Symptoms of hypoglycemia may include headache, severe hunger, nausea, fatigue, confusion, and decreased consciousness; in case of these symptoms, immediate intake of sugar or informing healthcare personnel is essential. During the use of this medication, regular meals, exercise, and weight management are important, and blood sugar control should be monitored periodically. In case of overdose, severe hypoglycemia may occur, requiring immediate emergency treatment, and it is necessary to quickly consume more than 20g of sugar in such cases. Safety and efficacy in children have not been established, and dosage adjustment is necessary for elderly patients considering decreased kidney function. This medication should be kept out of the reach of children and stored in its original container to prevent degradation of quality.
Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, decreased concentration, decreased agility or drive, depression, confusion, speech abnormalities, aphasia, visual impairment, tremor, incomplete paralysis, perception abnormalities, dizziness, weakness, loss of self-control, transient mental confusion, seizures, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, feeling of fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorder, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, granulocytopenia, agranulocytosis, pancytopenia, itching, urticaria, rash, dyspnea, hypotension, shock, anaphylaxis, angioedema, skin and mucous membrane syndrome, allergic vasculitis, skin photoreaction, decreased serum sodium concentration, taste disorders, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, joint pain, dyspepsia, facial swelling, erectile dysfunction, facial flushing, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, and it is advisable to keep it at room temperature between 1 to 30 degrees Celsius. Storing it this way will help maintain the drug's effectiveness for a longer period.
Green rectangular tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 2mg
Tablet · Prescription medication
Hybeast Pharmaceutical Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.